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Smooth pursuita b s t r a c t
Previous studies have shown that smooth pursuit eye movements are impaired in patients with schizo-
phrenia. However, under normal viewing conditions, targets move not only in the frontoparallel plane
but also in depth, and tracking them requires both smooth pursuit and vergence eye movements.
Although previous studies in humans and non-human primates suggest that these two eye movement
subsystems are relatively independent of one another, to our knowledge, there have been no prior studies
of vergence tracking behavior in patients with schizophrenia. Therefore, we have investigated these eye
movements in patients with schizophrenia and in healthy controls. We found that patients with schizo-
phrenia exhibited substantially lower gains compared to healthy controls during vergence tracking at all
tested speeds (e.g. 0.25 Hz vergence tracking mean gain of 0.59 vs. 0.86). Further, consistent with previ-
ous reports, patients with schizophrenia exhibited signiﬁcantly lower gains than healthy controls during
smooth pursuit at higher target speeds (e.g. 0.5 Hz smooth pursuit mean gain of 0.64 vs. 0.73). In addi-
tion, there was a modest (r0.5), but signiﬁcant, correlation between smooth pursuit and vergence track-
ing performance in patients with schizophrenia. Our observations clearly demonstrate substantial
vergence tracking deﬁcits in patients with schizophrenia. In these patients, deﬁcits for smooth pursuit
and vergence tracking are partially correlated suggesting overlap in the central control of smooth pursuit
and vergence eye movements.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Previous eye tracking studies in patients with schizophrenia have
reported abnormalities in their eyemovements; speciﬁcally, smooth
pursuit and antisaccades (for reviews see Levy et al., 1994;
Rommelse, Van der Stigchel, & Sergeant, 2008; Smyrnis, 2008;
Turetsky et al., 2007). The smooth pursuit deﬁcits associated with
schizophrenia were ﬁrst observed by Diefendorf and Dodge (1908)
and, since then, smooth pursuit eye movement dysfunction has con-
sistently been found in individuals with schizophrenia (O’Driscoll &
Callahan, 2008; Smyrnis, 2008; Turetsky et al., 2007). However,
under normal viewing conditions, targets move not only in the
frontoparallel plane but also in depth, and tracking requires both
smooth-pursuit eye movements, guided primarily by retinal slip
velocity, as well as vergence eye movements guided primarily by
binocular disparity, blur, and motion-in-depth signals. Psychophys-
ical observation in humans (Rashbass & Westheimer, 1961; Regan,Erkelens, & Collewijn, 1986; Semmlow, Yuan, & Alvarez, 1998),
and electrophysiological studies in non-human primates (Gamlin
& Clarke, 1995; Gamlin & Yoon, 2000; Gamlin, 2002) suggest that
these two eye movement subsystems are relatively independent of
one another. Nevertheless, the cortical substrates of vergence eye
movements include areas such as the frontal eye ﬁelds (FEF) (e.g.
Fukushima et al., 2002, 2004; Gamlin & Yoon, 2000; Gurler et al.,
2011), which have been implicated in the smooth pursuit deﬁcits
in schizophrenia (Goldman-Rakic & Selemon, 1997; Holzman,
2000; Levy et al., 2010). Based on this, it seems plausible that
patientswith schizophreniamight exhibit vergence tracking deﬁcits.
However, to the best of our knowledge, there have been no reports
on vergence tracking performance in patients with schizophrenia.
Therefore, we investigated dynamic aspects of vergence tracking in
healthy controls and patients with schizophrenia.2. Methods
Twenty-four subjects with schizophrenia and schizoaffective
disorder (SZ) were recruited from the outpatient psychiatry clinic
Fig. 1. Illustration of vergence pursuit and smooth pursuit stimuli used in the
dynamic eye movement experiment. The arrows represent the direction of target
motion and were not presented to the participant during the experiment. (A)
Vergence tracking target. The white circle represents the holographic diffuser with
inscribed black dot backlit by a white LED. The vergence target is mounted on the
moving chassis of an X–Y plotter. (B) Smooth pursuit target. The white circle with a
centered black dot represents the smooth pursuit target, which was presented on
the ﬂat screen monitor. Vergence tracking and smooth pursuit targets were
presented in separate trials.
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study. Twenty-three healthy controls (HC), matched on age,
gender, ethnicity, and parental occupation, were recruited by
advertisement in ﬂyers and the university’s newspaper. Exclusion
criteria were major medical conditions, substance abuse within
six months of examination, previous serious head injury, a neuro-
logical disorder, and loss of consciousness for more than 2 min. The
study was approved by the Institutional Review Board of the
University of Alabama at Birmingham in accordance with The Code
of Ethics of theWorld Medical Association (Declaration of Helsinki)
for experiments involving humans, and all subjects gave written
informed consent. Before signing consent, each SZ subject com-
pleted an Evaluation to Sign Consent Form.
Diagnoses were established using subjects’ medical records and
the Diagnostic Interview for Genetic Studies (DIGS) (Nurnberger
et al., 1994). General cognitive function was characterized by the
Repeatable Battery for the Assessment of Neuropsychological
Status (RBANS) (Randolph et al., 1998). The Brief Psychiatric Rating
Scale (BPRS) (Overall & Gorham, 1962) and its positive and nega-
tive subscales were used to assess mental status and symptom
severity.
Participants were also excluded during vision screening if they
had acuity of less than 20/40 in either eye, more than 2 lines of dif-
ference in visual acuity between the eyes, or lack of stereopsis.
Each subject was examined by the same doctor who was masked
to the patient’s psychiatric diagnosis. Three participants (SZ = 1)
were excluded during vision screening and 4 (SZ = 3) withdrew
or were lost to follow up. Forty participants, 20 SZ and 20 HC, com-
pleted the study and were included in the ﬁnal analyses.
2.1. Binocular vision and vergence testing
All visual measures were taken with the subject’s habitual
prescription in place. Distance visual acuity was measured in each
eye with a projected Snellen chart at 20 feet. Near visual acuity was
screened in each eye with a 20/30 isolated line of letters. Binocular
vision testing included ﬁxation disparity (Saladin card), ocular
alignment with cover test at distance and near, near point of con-
vergence break (NPC) and recovery, positive fusional vergence at
near break and recovery (prism bar), stereo acuity (Randot Stereo),
accommodative amplitudes (push-up) for non-presbyopes, and
distance and near auto-refraction.
Based on these static measures, we have previously reported for
this cohort of patients that their mean NPC (5.5 cm) was not signif-
icantly different from healthy controls (4.4 cm), and that they did
not exhibit convergence insufﬁciency more frequently than
healthy controls (Bolding et al., 2012).
2.2. Eye tracking tasks
All of the eye tracking experiments were performed in a dark-
ened room. Each task lasted 60 s and there was a 20 s gap between
each task. The task order was randomized for each participant. A
chin rest and pads placed against the temples were used to mini-
mize head movement. The chin rest was adjusted so that the
bridge of the participant’s nose (midpoint between the eyes) was
level with the vergence tracking target and the center of the CRT
described below. Eye movement data was collected with a head
mounted, dual camera, video eye tracker with a 500 Hz sample rate
(Eyelink II, SR Research). Head movement was tracked so that
residual head movement could be removed from the eye tracking
signal. Eye tracking was calibrated at the start of the session using
a 9-point calibration procedure and a 1-point drift correction was
performed before each task.
For the smooth pursuit task in the frontoparallel plane, we used
a CRT with a ﬂat screen set at a refresh rate of 75 Hz. The screenwas 60 cm from the participant. The target was a 1 diameter
white disk with a 0.2 black dot in the center (Fig. 1B). The target
was presented on a black background and the brightness was
matched to that of the vergence target described below. The
smooth pursuit target moved horizontally with a constant speed,
triangular waveform over a range of 14. The speed of the target
was 5.6/s, 14/s, or 28/s.
The vergence tracking target was mounted on the carriage of an
HP 7044A XY ﬂatbed recorder. This recorder has a 28  43 cm
range of travel, accuracy of 0.2% full-scale, acceleration of
5080 cm/s2 and a slew rate of 104 cm/s. The target was a small disk
of holographic diffuser material with a black dot inscribed in the
center (Fig. 1A). It was illuminated with a white LED via a ﬁber
optic bundle. In order to match the pursuit target, the vergence tar-
get was sized so that it would form a 1 disk at the distance of the
CRT. The target moved along a line that passed through the bridge
of the participants nose and the center of the CRT described above.
During the vergence tracking task, the target motion had a con-
stant speed, triangular waveform in depth over a range of 20 cm
starting from 30 cm away from the subject. The speed of the target
was 2 cm/s, 4 cm/s, or 10 cm/s. With this arrangement, because the
target speed through space was constant, the angular speed varied
with target distance. However, if the angular speed is held con-
stant, the target appears to decelerate as it approaches the subject
and accelerate as it recedes. The average angular speed of the tar-
get (i.e. the angular difference between 10 cm and 30 cm divided
by half the period) was 2.2, 4.4, or 11/s respectively for a subject
with a 6 cm inter-pupillary distance.2.3. Data analyses
For initial analysis, eye movements were decomposed into sacc-
adic and slow components. Saccades were identiﬁed using velocity,
and acceleration thresholds of 22/s and 4000/s2 respectively.
Since we were interested in saccades that occurred during pursuit
and tracking eye movements that could exceed 22/s, the velocity
threshold was increased by the average velocity of the eye over the
preceding 40 ms (up to a limit of 60/s).
Table 1
Demographics and clinical measures.a
Characteristic HC (n = 20) SZ (n = 20) t/v2 p-Value
Age, years 36.3 ± 11.3 39.0 ± 11.4 0.75 0.46
Gender, F/M 8/12 9/11 0.10 0.75
Ethnicity, AA/Cb 10/10 14/6 0.94 0.33
Parental SESc 6.7 ± 5.1 6.8 ± 5.0 0.07 0.94
RBANSd
Total index 87.2 ± 12.5 73.7 ± 10.2 6.16 0.002
Immediate memory 88.6 ± 15.3 77.5 ± 12.3 6.43 0.03
Visuospatial 79.9 ± 15.7 79.9 ± 15.7 2.31 0.69
Language 95.5 ± 14.4 87.3 ± 13.7 2.95 0.11
Attention 96.4 ± 20.8 82.3 ± 12.9 4.58 0.03
Delayed memory 91.8 ± 8.4 72.5 ± 20.7 5.38 0.001
BPRSe
Total – 29.2 ± 6.8 – –
Positive – 4.5 ± 2.6 – –
Negative – 4.3 ± 2.0 – –
Notes: v2 includes Yate’s correction.
a Mean ± SD; SZ, patients with schizophrenia; HC, healthy controls.
b AA, African American; C, Caucasian.
c Socioeconomic status; ranks determined from Diagnostic Interview for Genetic
Studies (1–18 scale); higher rank (lower numerical value) corresponds to higher
socioeconomic status; information not available for 1 SZ.
d Repeatable Battery for the Assessment of Neuropsychological Status; data not
available for 2 SZ and 2 HC.
e Brief Psychiatric Rating Scale (1–7 scale); positive (conceptual disorganization,
hallucinatory behavior, and unusual thought content); negative (emotional with-
drawal, motor retardation, and blunted affect); data not available for 2 SZ.
Fig. 2. Sixty seconds vergence tracking showing examples of the performance of a
healthy control (A–C) and a patient with schizophrenia (D–F) (0.1 Hz; target
speed = 4 cm/s). (A and D) Plots of left and right eye positions during vergence
tracking. (B and E) Plots of versional (horizontal average) eye position during
vergence tracking. (C and F) Plots of vergence angle during vergence tracking. Solid
lines, eye position; dashed lines, target position.
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rated into a saccadic component and a pursuit component. In the
missing parts of each component, the velocity was set to zero.
Because participants tended to make saccades in one direction
more than the other, the pursuit component was detrended. The
saccadic component was used to calculate saccade frequency,
mean duration, and mean velocity. The pursuit component was
compared to the target motion to estimate the gain and error of
eye position with respect to the target. Eye movement error was
calculated by subtracting the target motion from the eye motion.
The phase and amplitude of the pursuit component was estimated
by ﬁtting a parameterized target waveform to the actual eye
motion. Gain was calculated as the ratio of the peak-to-peak ampli-
tudes of the ﬁtted eye motion and the actual target motion (in
degrees). Tracking error for a trial was deﬁned as the standard
deviation of the difference between the target position and gaze
position (gaze error, in degrees) over the course of the task trial.
2.4. Medication
None of the healthy controls were taking antipsychotics or anti-
depressants. Eighteen patients with schizophrenia were taking
atypical antipsychotics and two were taking no antipsychotics.
Ten patients with schizophrenia were taking antidepressants.
There were no signiﬁcant differences in the eye movement
measures between the ten patients with schizophrenia taking anti-
depressants and the ten who were not. Four patients with schizo-
phrenia were taking anticholinergic medication, but there were no
signiﬁcant differences in their eye movement measures compared
to the other patients.
3. Results
There were no signiﬁcant differences between the patients with
schizophrenia and healthy controls for their age, gender, race,
smoking, or parental socioeconomic status (Table 1).
3.1. Vergence tracking
Fig. 2 shows example eye movement traces for 0.1 Hz, 4 cm/s
vergence tracking trials. Compared to the healthy control subject,
the patient with schizophrenia is clearly unable to track the target
effectively. When compared to healthy controls, patients with
schizophrenia exhibited signiﬁcantly lower gains during vergence
tracking at all speeds (Fig. 3A). The difference in gains between
the patients with schizophrenia and healthy controls became lar-
ger with higher target speeds (Fig. 3A; Table 2). Furthermore, the
patients with schizophrenia showed larger tracking errors than
healthy controls at all target speeds (Fig. 3B).
3.2. Smooth pursuit
Consistent with previous reports, the patients with schizophre-
nia exhibited lower gains than healthy controls during smooth
pursuit. The difference increased with higher target speeds
(Table 2). The patients with schizophrenia showed larger tracking
errors than healthy controls at all target speeds. Gain decreased
and tracking error increased with higher target speeds (Fig. 3B
and D).
3.3. Relationship between vergence tracking and smooth pursuit
performance
Healthy controls exhibited no signiﬁcant correlation between
their performance on smooth pursuit and vergence tracking tasks
(Fig. 4A–C). In contrast, the patients with schizophrenia exhibiteda signiﬁcant, albeit modest, correlation in their performance on
smooth pursuit and vergence tracking tasks at all tested speeds
(Fig. 4D–F).4. Discussion
In this study, we evaluated dynamic aspects of vergence eye
movements in a population of patients with schizophrenia. To
evaluate their performance, we compared their vergence eye
movements to that of a group of matched healthy controls. We
Fig. 3. Vergence tracking and smooth pursuit performance measures for healthy controls and patients with schizophrenia showing impaired performance in the patient
population. Panels (A and B) show the gain for each group (mean ± SE) during vergence tracking and smooth pursuit respectively. Patients with schizophrenia exhibited
reduced gain compared to healthy controls in all conditions. Panels (C and D) show the tracking error for each group (mean ± SE) during the vergence tracking and smooth
pursuit respectively. Patients with schizophrenia exhibited increased tracking error compared to healthy controls in all conditions. *p < .05; **p < .005.
Table 2
Smooth pursuit and vergence tracking gains.
Eye tracking performance
measure
HC mean SZ mean t p-
Value
Smooth pursuit gain
0.2 Hz, 5.6/s 0.84 ± 0.11 0.80 ± 0.16 1.12 0.133
0.5 Hz, 14/s 0.73 ± 0.14 0.64 ± 0.18 1.94 0.029
1.0 Hz, 28/s 0.45 ± 0.17 0.35 ± 0.19 1.92 0.030
Vergence tracking gain
0.05 Hz, 2 cm/s 0.90 ± 0.32 0.67 ± 0.39 2.17 0.036
0.1 Hz, 4 cm/s 0.88 ± 0.28 0.65 ± 0.34 2.46 0.018
0.25 Hz, 10 cm/s 0.86 ± 0.27 0.59 ± 0.31 3.10 0.003
Mean ± SD; SZ, patients with schizophrenia; HC, healthy controls.
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both in measures of vergence tracking gain and vergence tracking
accuracy. Importantly, this cohort of patients were not signiﬁcantly
different from healthy controls in their ability to converge to static
targets (Bolding et al., 2012).4.1. Reductions in gain of tracking eye movements in patients with
schizophrenia
We observed, as others have (Cerbone et al., 2003; Ettinger
et al., 2003; Hong, Avila, & Thaker, 2005; Hutton et al., 2001;
Smyrnis et al., 2007; Sweeney et al., 1998), that the smooth pursuit
gain deﬁcit was dependent on target velocity and that the differ-
ence between the schizophrenia group and healthy controls grew
as velocity increased. Similarly, vergence tracking gain was depen-
dent on target velocity and the difference between the groups
increased as target velocity increased. Overall, the vergence track-
ing gain deﬁcit was: (1) more pronounced than the deﬁcit in
smooth pursuit gain and, (2) these deﬁcits were seen at lower
target speeds. The ﬁrst observation might be explained by differ-
ence in difﬁculties of the two tasks. For a target moving at a con-
stant velocity through space, the angular velocity isapproximately constant for smooth pursuit but a tangent function
for vergence tracking. On the other hand, the speed of the target
through 3D space was linear for both conditions, so it is not clear
that one of these two tasks is more difﬁcult than the other, espe-
cially since normal individuals were able to perform the vergence
task with a gain of close to 1.0.
The ﬁrst observation might also be explained by the inability of
the subjects to perform compensatory ‘‘catch up’’ vergence eye
movements. During periods of low gain smooth pursuit, ‘‘catch
up’’ saccades are used to compensate for poor smooth pursuit gain
(Flechtner et al., 1997; Friedman, Jesberger, & Meltzer, 1991;
Haarmeier, 1999; Levin et al., 1988). In contrast, during low gain
vergence tracking we and others have observed few, if any, ‘‘catch
up’’ vergence eye movements (Rambold et al., 2009; Semmlow,
Pedrono, & Alvarez, 2007). However Semmlow, Hung, and
Ciuffreda (1986) originally reported that under these conditions
when the vergence angle fails to match target vergence angle, tran-
sient ‘‘catch up’’ vergence responses occur that effectively increase
vergence gain and reduce vergence tracking error. The differences
between the results of these various studies have not been
resolved.
The second observation that vergence tracking gain was
reduced at lower target speeds than smooth pursuit is consistent
with what is known about the visuomotor control of these eye
movements. Early studies showed that the frequency response of
vergence eye movements was substantially lower than that of
smooth pursuit eye movements (Rashbass & Westheimer, 1961).
Later studies showed that while smooth vergence tracking eye
movements saturated at disparity velocities of 5–7/s (Semmlow,
Hung, & Ciuffreda, 1986), smooth pursuit eye movements
saturated at target velocities of 100/s (Leigh & Zee, 2006).4.2. Vergence tracking and smooth pursuit deﬁcits are correlated
We observed that vergence tracking gain and smooth pursuit
gain were modestly correlated in individuals with schizophrenia.
Fig. 4. Correlation of vergence tracking and smooth pursuit gain. The relationship
between vergence tracking and smooth pursuit gain for healthy controls at target
speeds of: (A) 5.6/s smooth pursuit; 2 cm/s vergence tracking (r = 0.08; p = 0.73);
(B) 14/s smooth pursuit; 4 cm/s vergence tracking; (r = 0.18, p = 0.41); (C) 28/s
smooth pursuit; 10 cm/s vergence tracking (r = 0.08, p = 0.71). Overall, there was no
signiﬁcant correlation between vergence pursuit gain and smooth pursuit gain in
healthy controls. The relationship between vergence tracking and smooth pursuit
gain for patients with schizophrenia for target speeds of (D) 5.6/s smooth pursuit;
2 cm/s vergence tracking (r = 0.53, p = 0.006); (E) 14/s smooth pursuit; 4 cm/s
vergence tracking (r = 0.52, p = 0.007); (F) 28/s smooth pursuit; 10 cm/s vergence
tracking (r = 0.45, p = 0.03). Overall the patients with schizophrenia exhibited
signiﬁcant correlations between vergence tracking gain and smooth pursuit gain.
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gence tracking and smooth pursuit gain varied much less, so any
potential correlation was obscured. The observation of a correla-
tion between vergence tracking gain and smooth pursuit gain in
individuals with schizophrenia is consistent with our current
knowledge of the visuomotor control of these eye movements. Psy-
chophysical observation in humans (Rashbass & Westheimer,
1961; Regan, Erkelens, & Collewijn, 1986; Semmlow, Yuan, &
Alvarez, 1998), and electrophysiological studies in non-human pri-
mates (Gamlin & Clarke, 1995; Gamlin & Yoon, 2000; Gamlin,
2002) suggest that these two eye movement subsystems are rela-
tively independent of one another. However, they are not entirely
independent since some neurons in the FEF (Akao et al., 2005b;
Fukushima et al., 2002), MST (Akao et al., 2005a), and cerebellum
(Nitta et al., 2008) of macaques are sensitive to both vergence
tracking and smooth pursuit eye movements. In addition, our
recent fMRI studies in normal subjects show that there is partial
overlap in the FEF regions controlling vergence tracking and
smooth pursuit eye movements (Gurler et al., 2011). Thus, from
these data, we might expect a modest correlation between the per-
formance of vergence tracking and smooth pursuit in patients with
schizophrenia.
4.3. Medication
Eighteen of the participants with schizophrenia in this study
were taking atypical antipsychotics. However, although the effect
of medication has not been systematically evaluated, smoothpursuit deﬁcits have been observed not only in medicated
patients with schizophrenia, but also in unmedicated and medi-
cation naïve patients (Friedman, Jesberger, & Meltzer, 1992;
Holzman et al., 1975; Reilly et al., 2008; Ross et al., 1998;
Sweeney et al., 1994). Therefore, while atypical antipsychotics
do not cause the smooth pursuit deﬁcits observed in schizophre-
nia, we cannot rule out the possibility that atypical antipsychot-
ics have some affect on vergence eye movements. Additional
studies are needed to investigate the effect of commonly pre-
scribed antipsychotics on vergence eye movements and binocular
vision.
4.4. Etiology of vergence tracking and smooth pursuit deﬁcits
Previous psychophysical studies have suggested that the deﬁ-
cits seen in smooth pursuit eye movements in patients with
schizophrenia are due to deﬁcits in visual motion processing,
especially velocity discrimination (e.g. Butler & Javitt, 2005;
Chen et al., 1999, 2003; Clementz, McDowell, & Dobkins, 2007;
Tadin et al., 2006). Further, recent fMRI studies in patients with
schizophrenia have reported that there is reduced activity in
the human motion-selective complex (hMT+) and the parietal
regions that subserve the processing of visual motion information
for smooth pursuit eye movements (Lencer et al., 2011; Nagel
et al., 2012). Given that these same cortical regions process not
only visual motion signals but also the disparity and motion-in-
depth signals that guide vergence tracking (e.g. Cottereau,
McKee, & Norcia, 2014; Huk 2012; Cottereau et al., 2011;
Likova & Tyler, 2007; Rokers, Cormack, & Huk, 2009), our ﬁnding
that the gain in vergence tracking is reduced in patients with
schizophrenia is consistent with these previous ﬁndings. Further
studies are therefore clearly needed that use psychophysics and
fMRI to investigate the processing of both cyclopean and non-
cyclopean disparity and motion-in-depth signals in patients with
schizophrenia.
In addition, other studies indicate the deﬁcits seen in smooth
pursuit eye movements in patients with schizophrenia are due to
deﬁcits in the integration of the retinal and extra-retinal (efference
copy) signals that are required for predictive, closed-loop smooth
pursuit (e.g. Hong et al., 2008; Spering et al., 2013; Sweeney
et al., 1998; Thaker et al., 1999). The appropriate neural signals
for such sensorimotor integration are found in the frontal eye ﬁelds
of non-human primates (e.g. Gottlieb, Bruce, & MacAvoy, 1993;
MacAvoy, Gottlieb, & Bruce, 1991; Mahaffy & Krauzlis, 2011;
Tanaka & Lisberger, 2001). Given that the frontal eye ﬁelds also
contain neurons related to vergence eye movements (e.g.
Fukushima et al., 2002, 2004; Gamlin & Yoon, 2000), the reduction
in the gain of vergence tracking in patients with schizophrenia
might similarly be due to deﬁcits in the integration of the disparity
and extra-retinal vergence signals required for closed-loop
vergence tracking. Further studies are therefore needed that inves-
tigate the ability of patients with schizophrenia to integrate the
disparity and extra-retinal vergence signals required for closed-
loop vergence tracking.
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